Floatz logo

lv009

Acute Lymphoblastic Leukemia (ALL), Adult

PersonGen BioTherapeutics (Suzhou) Co., Ltd.Early Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

73 Active assets in the Acute Lymphoblastic Leukemia (ALL), Adult cohort.

Asset / SponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
Shanxi Bethune Hospital
Phase 4A
Cyclophosphamide
The First Affiliated Hospital of Zhengzhou University
Phase 4BBB
METHOTREXATE
PETHEMA Foundation
Phase 4BBB
DEXAMETHASONE
Shanxi Bethune Hospital
Phase 4BBB
Cytosin-Arabinosid
PETHEMA Foundation
Phase 4BBB

View all 50 →

Same molecule, other indications

lv009 is also rated in:

non-Hodgkin lymphomaDormant
CC
Indicative ·
44 / 100
View asset →
acute lymphoblastic leukemiaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →